Feedback / Questions
MHB088C - Minghui Pharma
https://www.prnewswire.com/news-releases/minghui-pharmaceutical-to-present-the-phase-iii-study-of-mhb088c-b7-h3-adc-for-the-treatment-of-patients-with-recurrent-or-metastatic-solid-tumors-in-late-breaking-oral-presentation-at-the-2024-asco-annual-meeting-302139458.html
May 8, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next